Genital wart. Viral warts
Conditions
Interventions
Intervention 1: Intervention group: Recipient of topical 5-FU 5% ointment (Efudex Co) three times a week (n=30) for one month. Intervention 2: Intervention group: Receiving topical calcipotriol ointme
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who are diagnosed with genital warts for the first time or who have not received treatment for genital warts in the last three months. Do not have any other skin disease
Exclusion criteria
Exclusion criteria: Patients with immune system dysfunction Having a previous history of allergy to the studied drugs Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Location of the lesion. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.;The size of the lesion. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.;Number of genital warts. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of the disease. Timepoint: Before treatment, 1 and 3 months after treatment. Method of measurement: Physical examination.;Side effects. Timepoint: 1 and 3 months after treatment. Method of measurement: Physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmadreza Zamani
Ahvaz University of Medical Sciences
Outcome results
None listed